Finance

Beta
Lists
TVTX:NASDAQ
Travere Therapeutics Inc
$59.03
+2.32%
(+1.34) 1D
$59.17
+0.24% (+0.14)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVTX...
Open
$57.85
High
$60.10
Low
$57.29
Mkt. cap
5.49B
Avg. vol.
2.14M
Volume
2.70M
52-wk high
$60.10
52-wk low
$14.36
EPS
-$0.27
Beta
1.13
Shares outstanding
92.99M
No. of employees
497
Open
$57.85
High
$60.10
Low
$57.29
Mkt. cap
5.49B
Avg. vol.
2.14M
Volume
2.70M
52-wk high
$60.10
52-wk low
$14.36
EPS
-$0.27
Beta
1.13
Shares outstanding
92.99M
No. of employees
497
News stories
From sources across the web
About Travere Therapeutics Inc
CEO-
Employees497
Founded2011
Headquarters-
SectorBiotechnology
Websitetravere.com
Analyst ratings
Based on 12 analysts giving stock ratings to TVTX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for TVTX in the last 3 months.
Highest
Current $59.03
$70.00 (+18.58%)
Average
$58.33 (-1.19%)
Lowest
$43.00 (-27.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
$65.00
+10.1%
06/25/2026
Laura Chico
Wedbush
Buy
Maintained
$61.00
+3.3%
06/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$67.00
+13.5%
06/22/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$70.00
+18.6%
06/14/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$65.00
+10.1%
06/11/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
$56.00
-5.1%
06/02/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$49.00
-17%
06/03/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
$59.00
-0.1%
06/03/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
$60.00
+1.6%
06/02/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$53.00
-10.2%
05/29/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$50.00
-15.3%
05/06/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$52.00
-11.9%
05/05/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
$52.00
-11.9%
05/05/2026
Alex Thompson CFA
Stifel Nicolaus
Hold
Maintained
$43.00
-27.2%
05/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Reiterated
-
-
02/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
114.45M
164.86M
129.69M
127.20M
Cost of goods sold
50.88M
53.48M
60.42M
83.86M
Cost of revenue
50.88M
53.48M
60.42M
83.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
76.22M
86.45M
101.69M
80.25M
Operating expense
76.22M
86.45M
101.69M
80.25M
Total operating expenses
127.10M
139.93M
162.12M
164.11M
Operating income
-12.65M
24.93M
-32.43M
-36.92M
Other non operating income
-526.00K
487.00K
11.07M
-91.00K
EBT including unusual items
-12.74M
25.71M
-21.06M
-36.72M
EBT excluding unusual items
-12.74M
25.71M
-21.06M
-36.72M
Income tax expense
20.00K
8.00K
921.00K
-120.00K
Effective tax rate
-0.16%
0.03%
-4.37%
0.33%
Other operating expenses
-
-
-
-
Net income
-12.76M
25.71M
2.73M
-37.10M
Net profit margin
-11.14%
15.59%
2.10%
-29.17%
Earnings per share
0.13
0.59
0.37
0.05
Interest and investment income
3.29M
3.05M
2.59M
2.58M
Interest expense
-2.85M
-2.75M
-2.30M
-2.30M
Net interest expenses
441.00K
296.00K
296.00K
284.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.37M
40.72M
-14.29M
-11.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TVTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer